University of Alberta Begins First Gene Therapy Trial for Choroideremia in Canada

The University of Alberta has recently begun the enrolling and dosing of subjects in a Phase II clinical trial for a gene therapy treatment of choroideremia, a rare inherited disorder where the capillaries of the choroid degenerate, causing blindness by around middle age.

This gene therapy, in which a viral vector carrying a working copy of the REP1 gene is introduced via sub-retinal injection, was developed by NightstaRx, a UK-based biopharmaceutical company, specializing in the development of therapies for retinal dystrophies. The current phase of this trial involves six subjects, all of them men.

Ian MacDonald, Professor of Ophthalmology and Visual Sciences at the University of Alberta and leader of the clinical research team, says, “It’s a great privilege to be able to do something very positive for people with choroideremia. People have hoped for this for a long time.”

Further Information: http://www.albertahealthservices.ca/11502.asp

Featured Posts

Eye Recommend Acquires Digital ECP

Doctors Eye Care Co-Op Ltd. (operating as Eye Recommend) and Digital ECP Inc. announced that Eye Recommend has acquired Digital ECP Inc. effective September 30, 2022.

Learn More

Vintage is Back with ic! berlin’s Geoffrey

Introduced in the Acetate Hybrid Collection launched in March from ic! berlin, the Geoffrey frame reintroduces the vintage square style we all love with bold new colourways.

Read more

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Read more

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more

Eye Recommend Acquires Digital ECP

Doctors Eye Care Co-Op Ltd. (operating as Eye Recommend) and Digital ECP Inc. announced that Eye Recommend has acquired Digital ECP Inc. effective September 30, 2022.

Learn More

Vintage is Back with ic! berlin’s Geoffrey

Introduced in the Acetate Hybrid Collection launched in March from ic! berlin, the Geoffrey frame reintroduces the vintage square style we all love with bold new colourways.

Read More

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Read More

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read More

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read More

Eye Recommend Acquires Digital ECP

Doctors Eye Care Co-Op Ltd. (operating as Eye Recommend) and Digital ECP Inc. announced that Eye Recommend has acquired Digital ECP Inc. effective September 30, 2022.

Learn More

Vintage is Back with ic! berlin’s Geoffrey

Introduced in the Acetate Hybrid Collection launched in March from ic! berlin, the Geoffrey frame reintroduces the vintage square style we all love with bold new colourways.

Read more

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Read more

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more

Eye Recommend Acquires Digital ECP

Doctors Eye Care Co-Op Ltd. (operating as Eye Recommend) and Digital ECP Inc. announced that Eye Recommend has acquired Digital ECP Inc. effective September 30, 2022.

Learn More

Vintage is Back with ic! berlin’s Geoffrey

Introduced in the Acetate Hybrid Collection launched in March from ic! berlin, the Geoffrey frame reintroduces the vintage square style we all love with bold new colourways.

Read more

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Read more

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more